← Back to Search

Active Treatment with Relaxation for Pediatric Cancer

N/A
Waitlist Available
Led By Robin S Tanner, BA
Research Sponsored by Geisinger Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Current patient at Geisinger Foss Clinic - oncology department with a diagnosis of cancer for more than 2 months prior to the study start
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measurement will be assessed through study completion, an average of 1 year
Awards & highlights

Study Summary

This study is evaluating whether relaxation therapy can help children with cancer.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measurement will be assessed through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and measurement will be assessed through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improved anxiety level
Secondary outcome measures
Change in levels of pain
Improved sleep habits

Trial Design

4Treatment groups
Active Control
Group I: Active Treatment with RelaxationActive Control1 Intervention
This subgroup comprises of patients who are currently receiving active treatment for their cancer diagnosis. They will be completing the pre-recorded relaxation audio therapy twice weekly prior to falling asleep.
Group II: Remission with RelaxationActive Control1 Intervention
This subgroup comprises of patients who are currently in remission for their cancer diagnosis. They will be completing the pre-recorded relaxation audio therapy twice weekly prior to falling asleep.
Group III: Active Treatment withoutActive Control1 Intervention
This subgroup comprises of patients who are currently receiving active treatment for their cancer diagnosis. They will not be asked to complete any additional relaxation therapy.
Group IV: Remission withoutActive Control1 Intervention
This subgroup comprises of patients who are currently in remission for their cancer diagnosis. They will not be asked to complete any additional relaxation therapy.

Find a Location

Who is running the clinical trial?

Geisinger ClinicLead Sponsor
148 Previous Clinical Trials
1,886,093 Total Patients Enrolled
Robin S Tanner, BAPrincipal InvestigatorGeisinger Clinic
Santisree Tanikella, MDPrincipal InvestigatorGeisinger Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Relaxation Therapy in Pediatric Oncology
Santisree Tanikella 2022. "Relaxation Therapy in Pediatric Oncology". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04719416.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top